438 Synergy between SEA-CD40 and chemotherapeutics drives curative antitumor activity in preclinical models

• Michael Schmitt,
• Weiping Zeng,
• Celine Jacquemont,
• Haley Neff-LaFord,
• Sahar Ansari

Affiliations

Michael Schmitt

Seattle Genetics, Bothell, WA, USA

Weiping Zeng

Aff314 grid.438014.aSeattle Genetics, Inc. Bothell WA USA

Celine Jacquemont

Aff5 Phenopath Seattle WA USA

Haley Neff-LaFord

Seattle Genetics, Bothell, WA, USA

Sahar Ansari

Seattle Genetics, Bothell, WA, USA